文献速递关节外科

血浆D-二聚体不能预测二期翻修关节置换术再植入的转归:一项初步研究

Plasma D-dimer Does Not Anticipate the Fate of Reimplantation in Two-stage Exchange Arthroplasty for Periprosthetic Joint Infection: A Preliminary Investigation.
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

本研究回顾性分析44例因假体周围感染(PJI)行二期翻修术的患者,评估再植入前血浆D-二聚体预测再植入后持续感染的价值。结果显示D-二聚体单独诊断准确性低(AUC 0.62),最佳阈值为3070 ng/mL,敏感性90%但特异性仅47%,且与无感染生存无显著关联。联合D-二聚体、ESR和CRP可提高特异性至91%。

要点

  • D-二聚体单独预测再植入后持续感染的准确性低(AUC 0.62)。
  • 最佳阈值3070 ng/mL时敏感性90%、阴性预测值94%,但特异性仅47%。
  • D-二聚体联合ESR和CRP特异性最高达91%。

核心结论

  • 在本初步系列中,D-二聚体单独准确性差,且与二期翻修再植入后无感染生存无关。
  • D-二聚体单独可用于排除PJI,联合ESR和CRP可考虑用于再植入时确认PJI诊断。

研究设计与样本

  • 再植入前检测血浆D-二聚体,随访平均503±135天,以Delphi标准定义再植入后感染持续或消失。

主要发现

  • ROC曲线分析显示D-二聚体AUC为0.62,准确性低,不能预测再植入后持续感染。
  • D-二聚体最佳阈值为3070 ng/mL,敏感性90%(95% CI 55.5%至99.7%),阴性预测值94%(95% CI 70.7%至99.1%),特异性47%(95% CI 29.8%至64.9%),阳性预测值33%(95% CI 25.5%至42.2%)。
  • D-二聚体联合ESR和CRP特异性最高,为91%(95% CI 75.6%至98%)。
  • 以3070 ng/mL为界,再植入后无感染生存曲线无显著差异(749天[95% CI 665至833天] vs 615天[95% CI 471至759天],p=0.052)。
  • 高ESR和CRP与再植入后持续感染无关联,但事件数很少,把握度不足。

关键数值与推荐

  • 持续感染定义依据Delphi标准:伤口愈合无瘘管、引流或疼痛;再植入后无因感染再次手术;无PJI相关死亡;任一项不满足即为持续感染。
  • D-二聚体最佳阈值3070 ng/mL由Youden指数确定,AUC 0.62,敏感性90%、特异性47%、阴性预测值94%、阳性预测值33%(95% CI见上)。
  • D-二聚体联合ESR和CRP特异性91%(95% CI 75.6%至98%)。

临床怎么用

  • D-二聚体单独不应用于预测再植入后持续感染或决定再植入时机。
  • D-二聚体单独阴性(<3070 ng/mL)可帮助排除PJI,但需结合其他指标。
  • 再植入时考虑联合检测D-二聚体、ESR和CRP以提高特异性确认PJI诊断。

局限性

  • 初步研究,样本量小(44例),事件数少,统计把握度不足。
  • 回顾性设计,17%患者失访未分析。
  • 随访时间仅至少1年,短于典型的2年。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory markers such as the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels have always been a part of the diagnostic criteria for periprosthetic joint infection (PJI), but they perform poorly anticipating the outcome of reimplantation. D-dimer has been reported in a small series as a potential marker to measure infection control after single-stage revisions to treat PJI. Nonetheless, its use to confirm infection control and decide the proper timing of reimplantation remains uncertain. QUESTIONS/PURPOSES: (1) What is the best diagnostic threshold and accuracy values for plasma D-dimer levels compared with other inflammatory markers (ESR and CRP) or what varying combinations of these tests are associated with persistent infection after reimplantation? (2) Do D-dimer values above this threshold, ESR, CRP, and varying test combinations at the time of reimplantation indicate an increased risk of subsequent persistent infection after reimplantation? METHODS: We retrospectively studied the electronic medical records of all 53 patients who had two-stage revisions for PJI and who underwent plasma D-dimer testing before reimplantation at one of two academic institutions from November 22, 2017 to December 5, 2020. During that period, all patients undergoing two-stage revisions also had a D-dimer test drawn. The minimum follow-up duration was 1 year. We are reporting at this early interval (rather than the more typical 2-year time point) because of the poorer-than-expected performance of this diagnostic test. Of these 53 patients, 17% (9) were lost to follow-up before 1 year and could not be analyzed; the remaining 44 patients (17 hips and 27 knees) were studied here. The mean follow-up was 503 ± 135 days. Absence or persistence of infection after reimplantation were defined according to the Delphi criteria. The conditions included in these criteria were: (1) control of infection, as characterized by a healed wound without fistula, drainage, or pain; (2) no subsequent surgical intervention owing to infection after reimplantation; and (3) no occurrence of PJI-related mortality. The absence of any of the aforementioned conditions until the final follow-up examination was deemed a persistent infection after reimplantation. Baseline patient characteristics were not different between patients with persistent infection (n = 10) and those with absence of it after reimplantation (n = 34) as per the Delphi criteria. Baseline patient characteristics evaluated were age, gender, self-reported race (white/Black/other) or ethnicity (nonHispanic/Hispanic), BMI, American Society of Anesthesiologists (ASA) status, smoking status(smoker/nonsmoker), and joint type (hip/knee). The optimal D-dimer threshold to differentiate between persistence of infection or not after reimplantation was calculated using the Youden index. A receiver operating characteristic curve analysis was performed to test the accuracy of D-dimer, ESR, CRP, and their combinations to establish associations, if any, with persistent infection after reimplantation. A Kaplan-Meier survival analysis (free of infection after reimplantation) with a log-rank test was performed to investigate if D-dimer, ESR, and CRP were associated with absence of infection after reimplantation. Survival or being free of infection after reimplantation was determined as per Delphi criteria. Alpha was set at p < 0.05. RESULTS: In the receiver operating characteristic curve analysis, with an area under the curve of 0.62, D-dimer showed low accuracy and did not anticipate persistent infection after reimplantation. The optimal D-dimer threshold differentiating between persistence of infection or not after reimplantation was 3070 ng/mL. When using this threshold, D-dimer demonstrated a sensitivity of 90% (95% CI 55.5% to 99.7%) and negative predictive value of 94% (95% CI 70.7% to 99.1%), but low specificity (47% [95% CI 29.8% to 64.9%]) and positive predictive value (33% [95% CI 25.5% to 42.2%]). Although D-dimer showed the highest sensitivity, the combination of D-dimer with ESR and CRP showed the highest specificity (91% [95% CI 75.6% to 98%]) defining the persistence of infection after reimplantation. Based on plasma D-dimer levels, with the numbers available, there was no difference in survival free from infection after reimplantation (Kaplan-Meier survivorship free from infection at minimum 1 year in patients with D-dimer below 3070 ng/mL versus survivorship free from infection with D-dimer above 3070 ng/mL: 749 days [95% CI 665 to 833 days] versus 615 days [95% CI 471 to 759 days]; p = 0.052). Likewise, there were no associations between high ESR and CRP levels and persistent infection after reimplantation, but the number of events was very small, and insufficient power is a concern with this analysis. CONCLUSION: In this preliminary series, with the numbers available, D-dimer alone had poor accuracy and was not associated with survival free from infection after reimplantation in patients who underwent two-stage exchange arthroplasty. D-dimer alone might be used to establish that PJI is unlikely, and the combination of D-dimer, ESR, and CRP should be considered to confirm PJI diagnosis in the setting of reimplantation.Level of Evidence Level IV, diagnostic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Pannu TS, Villa JM, Engh C, et al. Plasma D-dimer Does Not Anticipate the Fate of Reimplantation in Two-stage Exchange Arthroplasty for Periprosthetic Joint Infection: A Preliminary Investigation. Clin Orthop Relat Res. 2021. PMID: 33830953. doi:10.1097/CORR.0000000000001738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。